Full INTerpath-001 results show the individualized mRNA therapy plus pembrolizumab reduced recurrence risk in resected stage IIB-IV melanoma.
|Articles|November 1, 1997
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Type 2 Diabetes
- Volume 3
- Issue 10 Suppl
Diabetes: New Insights, Innovative Approaches
Author(s)Robert Henry, MD, Joel Zonszein, MD
Advertisement
Articles in this issue
almost 29 years ago
Goals and Objectivesalmost 29 years ago
Participating Facultyalmost 29 years ago
Declaring War on Diabetes: New Strategies for Old Battlesalmost 29 years ago
Roundtable Discussions - Diabetes Prevalence, Development and Progressionalmost 29 years ago
Roundtable Discussions - Diabetes Management Techniquesalmost 29 years ago
Selected Abstractsalmost 29 years ago
CME Quizalmost 29 years ago
BibliographyAdvertisement
Related to this article
Kidney Week 2026 abstracts show that AMKD progresses quickly in routine practice, with or without diabetes, despite background CKD therapy.
Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
A retrospective study suggests strength exercise may be a safer option than endurance exercise for some people with ACM.
Infant flu protection from maternal vaccination varied by timing, while pediatric vaccination fell to 49.4%, experts report at IDWeek 2026.
The NCCN’s latest esophageal/EGJ guidance raises durvalumab plus FLOT to a category 2A recommendation for PD-L1–negative, diffuse-type disease.
Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
The pilot pairs grocery stipends and community health worker support with members who have unmanaged diabetes and unmet social needs.
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
3
Pulmonary Embolism Can Affect Elite Athletes, Too: Samantha Pettigrew, MD
4
Uninsured Rate Rises to 11.2% as Coverage Erodes Before Medicaid Cuts
5